Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: Fast engraftment and low toxicity

Experimental Hematology

Volumn 34, Issue 12, 2006, Pages 1746-1752

  Bethge, Wolfgang A ^a   Haegele, Matthias ^a   Faul, Christoph ^a   Lang, Peter ^b   Schumm, Michael ^b   Bornhauser, Martin ^c   Handgretinger, Rupert ^b   Kanz, Lothar ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; FLUDARABINE; MELPHALAN; OKT 3; THIOTEPA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADENOVIRUS; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD34 SELECTION; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DENDRITIC CELL; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HAPLOIDY; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MORTALITY; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NATURAL KILLER CELL; NEUROPATHY; NEUROTOXICITY; NONHODGKIN LYMPHOMA; PNEUMONIA; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RELAPSE; STEM CELL; T CELL DEPLETION; T LYMPHOCYTE; THROMBOCYTE; VIRUS INFECTION;

ADULT; ANTIGENS, CD19; ANTIGENS, CD3; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; PILOT PROJECTS; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33751545241     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.08.009     Document Type: Article

References (35)

1. Martin P.J. Overview of marrow transplantation immunology. In: Blume K.G., Forman S.J., and Appelbaum F.R. (Eds). Thomas' Hematopoietic Cell Transplantation (2004), Blackwell Science, Inc., Malden, MA 16-30
2. Beatty P.G., Clift R.A., Mickelson E.M., et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313 (1985) 765-771
3. Anasetti C., Amos D., Beatty P.G., et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 320 (1989) 197-204
4. Ruggeri L., Capanni M., Urbani E., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
5. Anasetti C., Beatty P.G., Storb R., et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 29 (1990) 79-91
6. Bachar-Lustig E., Rachamim N., Li H.W., Lan F., and Reisner Y. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1 (1995) 1268-1273
7. Aversa F., Tabilio A., Terenzi A., et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84 (1994) 3948-3955
8. Aversa F., Tabilio A., Velardi A., et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339 (1998) 1186-1193
9. Aversa F., Terenzi A., Tabilio A., et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 23 (2005) 3447-3454
10. Barfield R.C., Otto M., Houston J., et al. A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation. Cytotherapy 6 (2004) 1-6
11. + natural killer (NK) cells obtained from mobilized haploidentical donors. [abstract]. Blood 102 (2003) 669a
12. Hale G., Kimberly K., Lovins R., et al. CD3 Depleted hematopoietic peripheral blood stem cell grafts in children with refractory hematologic malignancies undergoing transplantation from mismatched related donors. [abstract]. Blood 106 (2005) 451b
13. + cells using the CliniMACS device. J Hematother 8 (1999) 209-218
14. Leuner S., Arland M., Kahl C., et al. Enumeration of CD34-positive hematopoietic progenitor cells by flow cytometry: comparison of a volumetric assay and the ISHAGE gating strategy. Bone Marrow Transplant 22 (1998) 699-706
15. Bader P., Beck J., Frey A., et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 21 (1998) 487-495
16. Aversa F., Terenzi A., Felicini R., et al. Haploidentical stem cell transplantation for acute leukemia. Int J Hematol 76 Suppl 1 (2002) 165-168
17. + progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 27 (2001) 777-783
18. Handgretinger R., Klingebiel T., Lang P., Gordon P., and Niethammer D. Megadose transplantation of highly purified haploidentical stem cells: current results and future prospects. Pediatr Transplant 7 Suppl 3 (2003) 51-55
19. Martelli M.F., Aversa F., Bachar-Lustig E., et al. Transplants across human leukocyte antigen barriers. Semin Hematol 39 (2002) 48-56
20. + selected progenitor cells from alternative donors. Br J Haematol 124 (2004) 72-79
21. Nguyen S., Dhedin N., Vernant J.P., et al. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood 105 (2005) 4135-4142
22. Zanjani E.D., Almeida-Porada G., Livingston A.G., Zeng H., and Ogawa M. Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells. Exp Hematol 31 (2003) 406-412
23. Bornhauser M., Thiede C., Brendel C., et al. Stable engraftment after megadose blood stem cell transplantation across the HLA barrier: the case for natural killer cells as graft-facilitating cells. Transplantation 68 (1999) 87-88
24. Ruggeri L., Capanni M., Casucci M., et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94 (1999) 333-339
25. Jacquet E.G., Schanie C.L., Fugier-Vivier I., Willer S.S., and Ildstad S.T. Facilitating cells as a venue to establish mixed chimerism and tolerance. Pediatr Transplant 7 (2003) 348-357
26. Grimes H.L., Schanie C.L., Huang Y., et al. Graft facilitating cells are derived from hematopoietic stem cells and functionally require CD3, but are distinct from T lymphocytes. Exp Hematol 32 (2004) 946-954
27. Tanaka J., Imamura M., Kasai M., Asaka M., and Torok-Storb B. The role of accessory cells in allogeneic peripheral blood stem cell transplantation. Int J Hematol 69 (1999) 70-74
28. Fugier-Vivier I.J., Rezzoug F., Huang Y., et al. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J Exp Med 201 (2005) 373-383
29. + cells. Blood 99 (2002) 4174-4181
30. + progenitor cells: evidence for a deletion-based mechanism mediated by TNF-α. Blood 105 (2005) 2585-2593
31. + progenitors for autologous and allogeneic transplantation in children. Bone Marrow Transplant 24 (1999) 583-589
32. Ball L.M., Lankester A.C., Bredius R.G., et al. Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation. Bone Marrow Transplant 35 Suppl 1 (2005) S35-S38
33. Cook M., Briggs D., Craddock C., et al. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood 107 (2006) 1230-1232
34. Morrison B.E., Park S.J., Mooney J.M., and Mehrad B. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest 112 (2003) 1862-1870
35. Lang P., Schumm M., Greil J., et al. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study. Klin Padiatr 217 (2005) 334-338